In silico analysis of the immunological landscape of pituitary adenomas

Development of an Immune Infiltration-Related Prognostic Scoring System Based on the Genomic Landscape Analysis of Glioblastoma Multiforme

(2020) Guihua Tang et al.   Frontiers in Oncology

Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes

(2019) Garima Yagnik et al.   Oncotarget

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors

(2019) Sayka Barry et al.   ONCOGENE

Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors

(2019) Mizuto Sato et al.   Journal of Clinical Medicine

Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer

(2019) Sheng Yang et al.   CANCER SCIENCE

Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing's Disease

(2019) Hanna R Kemeny et al.   CLINICAL CANCER RESEARCH

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours

(2019) Pedro Marques et al.   Acta Neuropathologica Communications

Pangenomic Classification of Pituitary Neuroendocrine Tumors

(2019) Mario Neou et al.   CANCER CELL

The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy

(2018) Peng-fei Wang et al.   JOURNAL OF NEURO-ONCOLOGY

Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma

(2018) Nataliya Rohr-Udilova et al.   Scientific Reports

ArrayExpress update – from bulk to single-cell expression data

(2018) Awais Athar et al.   NUCLEIC ACIDS RESEARCH

Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer

(2018) Jyothi Thyagabhavan Mony et al.   Frontiers in Immunology

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013

(2016) Quinn T. Ostrom et al.   NEURO-ONCOLOGY

Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors

(2016) Yu Mei et al.   Oncotarget

Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy

(2016) Yu Zhang et al.   JAMA Oncology

Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas

(2015) Jian-Qiang Lu et al.   ENDOCRINE PATHOLOGY

Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future

(2015) Lieping Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS